{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:07:30Z","timestamp":1775218050608,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.preghy.2026.101427","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:08:26Z","timestamp":1770329306000},"page":"101427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antenatal aspirin prescription following the United States Preventive Services Task Force (USPSTF) 2021 practice update"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3826-3714","authenticated-orcid":false,"given":"Ashten B.","family":"Waks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Milone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan C.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2026.101427_b0005","doi-asserted-by":"crossref","unstructured":"Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. American College of Obstetricians and Gynecologists. Obstet Gynecol 2020;135:e237-60.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"10.1016\/j.preghy.2026.101427_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2026.101427_b0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","article-title":"Meta-analysis and systematic review to assess the role of soluble fms-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study","volume":"71","author":"Agrawal","year":"2018","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.preghy.2026.101427_b0020","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/HJH.0000000000002185","article-title":"Aspirin enhances trophoblast invasion and represses solumbe fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia","volume":"37","author":"Su","year":"2019","journal-title":"J. Hypertens."},{"issue":"10","key":"10.1016\/j.preghy.2026.101427_b0025","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1002\/jcp.28533","article-title":"Low-dose aspirin reduces hypoxia-induced sFlt-1 release via the JNK\/AP-1 pathway in human trophoblast and endothelial cells","volume":"234","author":"Lin","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.preghy.2026.101427_b0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnick","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10220","key":"10.1016\/j.preghy.2026.101427_b0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomized, double-blind, placebo-controlled trial","volume":"396","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.preghy.2026.101427_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247782","article-title":"Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: a systemic review and meta-analysis","volume":"16","author":"Van Doorn","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.preghy.2026.101427_b0045","doi-asserted-by":"crossref","unstructured":"Low-dose aspirin use for the prevention of morbidity and mortality From preeclampsia: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014;161(11):819-26.","DOI":"10.7326\/M14-1884"},{"key":"10.1016\/j.preghy.2026.101427_b0050","doi-asserted-by":"crossref","unstructured":"Low-dose aspirin use during pregnancy. ACOG Committee Opinion No. 743. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;132:e44\u201352.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"10.1016\/j.preghy.2026.101427_b0055","doi-asserted-by":"crossref","unstructured":"ow-dose aspirin use for the prevention of preeclampsia and related morbidity and mortality. US Preventive Services Task Force. JAMA 2021;326(12):1186-1191.","DOI":"10.1001\/jama.2021.14781"},{"issue":"1","key":"10.1016\/j.preghy.2026.101427_b0060","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1016\/j.ajog.2021.11.708","article-title":"Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia prevention \u2013 a quality improvement project","volume":"226","author":"Ayyash","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101427_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preghy.2023.09.002","article-title":"Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia","volume":"34","author":"Ayyash","year":"2023","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.preghy.2026.101427_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100663","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"Olson","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.preghy.2026.101427_b0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00404-022-06773-0","article-title":"Relationship between risk profile and prescription of low-dose aspirin for preeclampsia prevention","volume":"308","author":"Phelps","year":"2023","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.preghy.2026.101427_b0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101427_b0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101427_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: Systematic review and meta-analysis","volume":"218","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2026.101427_b0095","doi-asserted-by":"crossref","first-page":"e2142","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in 2019","volume":"5","author":"Wheeler","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.preghy.2026.101427_b0100","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1353\/hpu.2020.0123","article-title":"Preeclampsia risk and prevention among pregnant Medicaid beneficiaries","volume":"31","author":"Cross-Barnet","year":"2020","journal-title":"J. Health Care Poor Underserved"},{"issue":"3","key":"10.1016\/j.preghy.2026.101427_b0105","doi-asserted-by":"crossref","first-page":"B7","DOI":"10.1016\/j.ajog.2020.06.003","article-title":"Society for maternal-fetal medicine special statement: checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin","volume":"223","author":"Combs","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2026.101427_b0110","unstructured":"Boelig R, Wanees M, Zhan T, et al. Improving utilization of aspirin for prevention of preeclampsia in a high-risk urban cohort: A prospective cohort study."},{"issue":"2","key":"10.1016\/j.preghy.2026.101427_b0115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11606-020-06276-1","article-title":"Effect of an electronic health record \u201cnudge\u201d on opioid prescribing and electronic health record keystrokes in ambulatory care","volume":"36","author":"Ancker","year":"2021","journal-title":"J Gen Inten Med"},{"issue":"2","key":"10.1016\/j.preghy.2026.101427_b0120","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.039","article-title":"Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention\u2014quality metric and opportunities for quality improvement","volume":"229","author":"Combs","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2026.101427_b0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2026.101427_b0130","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A cost-benefit analysis of low-dose aspirin prophyalxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"365","key":"10.1016\/j.preghy.2026.101427_b0135","first-page":"e1","article-title":"Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia","volume":"217","author":"Tolcher","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2026.101427_b0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10995-021-03232-1","article-title":"Correlates of early prenatal care access among U.S. women: data from the pregnancy risk assessment monitoring system (PRAMS)","volume":"26","author":"Krukowski","year":"2022","journal-title":"Matern. Child Health J."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:31:20Z","timestamp":1775215880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778926000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"alternative-id":["S2210778926000140"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101427","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antenatal aspirin prescription following the United States Preventive Services Task Force (USPSTF) 2021 practice update","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101427"}}